NCT00962130撤回不适用
Glucose Monitoring in Tissue Transfers
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 试验地点
- 2
- 主要终点
- Perfusion and tissue transfer outcome during reconstructive surgery predicted by continuous glucose monitoring of tissue
研究概览
简要总结
The purpose of this study is to determine if 1) a continuous glucose monitoring system can measure glucose levels in transferred tissue during reconstructive surgery, and 2) if glucose measurements from a continuous glucose monitoring system correlate with tissue blood perfusion.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •presence of a soft tissue deformity where reconstruction with a pedicled or free tissue transfer is indicated
- •age 18 and over
- •ability to follow-up post-operatively
排除标准
- •age less than 18
- •prisoner status
- •inability to participate in a standard post-operative follow-up visit
研究组 & 干预措施
Blood Glucose Measurement
Experimental
Subjects have sensors placed on skin before surgery and these sensors will measure the subject's glucose until the third day after surgery when they are removed.
干预措施: Continuous glucose monitoring system (Device)
结局指标
主要结局
Perfusion and tissue transfer outcome during reconstructive surgery predicted by continuous glucose monitoring of tissue
时间窗: Up to three days post-op
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Use of Real-time Continuous Glucose Monitoring System in Patients With Type 1 Diabetes MellitusDiabetes Mellitus, Type 1NCT00824148Norwegian University of Science and Technology30
已完成
不适用
Continuous Glucose Monitoring by Subcutaneous Measurement Compared to Frequent Point of Care Measurement by Accu Chek in Critically Ill PatientsHyperglycaemiaHypoglycaemiaNCT01526044Onze Lieve Vrouwe Gasthuis178
撤回
不适用
Continuous Glucose Monitoring in InpatientsHyperglycemiaNCT06329297Parkview Health80
已完成
不适用
Efficacy of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes Mellitus on Multiple Daily Injections (MDI) or Continuous Subcutaneous Insulin Infusion (CSII) TherapyType 1 Diabetes MellitusNCT01104142DexCom, Inc.120
终止
不适用
Continuous Glucose Monitoring to Aid Weight Loss in PrediabetesWeight LossPreDiabetesNCT03844646Stanford University12